Pharmaceutical giants have put aside their business feuds to issue a joint statement about the coronavirus vaccine.
Rival executives are promising consumers that the urgency to develop a vaccine won’t undermine the scientific method or vigorous regulations. (MarketWatch)
A draft of the joint statement, still being finalized by companies including Pfizer Inc. PFE, -0.11%, Johnson & Johnson JNJ, -0.64% and Moderna Inc. MRNA, -3.45% and reviewed by the Wall Street Journal, commits to making the safety and well-being of vaccinated people the companies’ priority. The vaccine makers would also pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and in the manufacturing processes.
The companies might issue the pledge as soon as early next week, according to two people familiar with the matter. The statement would join a growing number of public assurances by industry executives that they aren’t cutting corners in their rapid testing and manufacturing of the vaccines.
“We believe this pledge will help ensure public confidence in the COVID-19 vaccines that may ultimately be approved and adherence to the rigorous scientific and regulatory process by which they are evaluated,” the draft statement says.